Quantcast
ZME Science
  • CoronavirusNEW
  • News
  • Environment
    • Climate
    • Animals
    • Renewable Energy
    • Eco tips
    • Environmental Issues
    • Green Living
  • Health
    • Alternative Medicine
    • Anatomy
    • Diseases
    • Genetics
    • Mind & Brain
    • Nutrition
  • Future
  • Space
  • Feature
    • Feature Post
    • Art
    • Great Pics
    • Design
    • Fossil Friday
    • AstroPicture
    • GeoPicture
    • Did you know?
    • Offbeat
  • More
    • About
    • The Team
    • Advertise
    • Contribute
    • Our stance on climate change
    • Privacy Policy
    • Contact
No Result
View All Result
ZME Science

No Result
View All Result
ZME Science
No Result
View All Result
Home Health & Medicine

Ketamine might relieve depression by repairing brain circuits

Ketamine works its magic in a two-step process that first starts with the repair of brain circuits damaged by depression.

Tibi Puiu by Tibi Puiu
April 12, 2019
in Health & Medicine, News, Science
Credit: Wikimedia Commons.
Credit: Wikimedia Commons.

Ketamine, an anesthetic but also a common recreational drug, is seen as a promising tool for fighting clinical depression. For years, ketamine research has exploded, revived by both scientific and anecdotal reports of its anti-depressant qualities. In just a matter of hours from its injection, ketamine relieves major depression symptoms even when other drugs fail, and these effects can last for more than a month. Scientists now think they know how ketamine works its magic — it repairs brain circuits damaged by depression-induced stress and then regenerates synapses.

The drug that mends brain connections

Study after study has found that ketamine does wonders for a patient’s mental health. A single dose of ketamine or esketamine (part of the ketamine molecule) not only relieves depression symptoms but also stops suicidal thoughts and ideation. Both esketamine and ketamine are similar insofar as they target the neurotransmitter glutamate, however, esketamine has less of a high, compared to ketamine. Esketamine is the main active ingredient in Spravato, a nasal spray that recently became the first Food and Drug Administration (FDA)-approved antidepressant based on ketamine.

Dr. Conor Liston, a neuroscientist and psychiatrist at Weill Cornell Medicine in New York, wanted to investigate how the anesthetic triggers these therapeutic effects. Liston and colleagues had read about previous research showing that ketamine creates new synapses (connections between brain cells). Their new study recently published in the journal Science sheds more light on this process, revealing a two-step process that starts with brain circuitry repair.

Liston and colleagues from the US and Japan experimented on mice which were given a stress hormone in order to exhibit depression-like symptoms. The rodents lost interest in eating sugary treats or exploring a maze, some of their favorite activities.

A special laser microscope that fired onto the animals’ brains revealed that the stress caused the mice to lose a lot of synapses. When a single dose of ketamine was administered to the depressed rodents, the researchers were stunned to see that the drug was restoring exactly the same synapses that had been earlier destroyed by exposure to chronic stress.

Get more science news like this...

Join the ZME newsletter for amazing science news, features, and exclusive scoops. More than 40,000 subscribers can't be wrong.

   

But this still wasn’t the full picture. The researchers then genetically modified mice so that their brain cells would glow under a microscope when active or get dimmer when inactive. By carefully observing the rodents following ketamine ingestion, the researchers could identify which brain circuits lit up together.

“Ketamine rescued behavior in mice that was associated with depression-like phenotypes by selectively reversing stress-induced spine loss and restoring coordinated multicellular ensemble activity in prefrontal microcircuits,” the authors wrote.

The findings showed that in only six hours after a dose of ketamine, brain circuits damaged by depression started firing together again in sync. The mice also started exhibiting normal behavior in this time period. What’s more, these changes took place before the synapses were restored — it was only after 12 hours following ketamine treatment that neural connections started forming. This means that ketamine might first need to repair brain circuits and only after this can it start off the synaptic regeneration process.

The new study might also explain why ketamine’s antidepressant effects wear off eventually — if the synaptic changes cannot be maintained, there will be a relapse. In the future, the researchers would like to find a way to maintain these brain circuits and prolong the treatment’s duration.

 

Tags: depressionketamine
Tibi Puiu

Tibi Puiu

Tibi is a science journalist and co-founder of ZME Science. He writes mainly about emerging tech, physics, climate, and space. In his spare time, Tibi likes to make weird music on his computer and groom felines.

Follow ZME on social media

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
  • Coronavirus
  • News
  • Environment
  • Health
  • Future
  • Space
  • Feature
  • More

© 2007-2019 ZME Science - Not exactly rocket science. All Rights Reserved.

No Result
View All Result
  • Coronavirus
  • News
  • Environment
    • Climate
    • Animals
    • Renewable Energy
    • Eco tips
    • Environmental Issues
    • Green Living
  • Health
    • Alternative Medicine
    • Anatomy
    • Diseases
    • Genetics
    • Mind & Brain
    • Nutrition
  • Future
  • Space
  • Feature
    • Feature Post
    • Art
    • Great Pics
    • Design
    • Fossil Friday
    • AstroPicture
    • GeoPicture
    • Did you know?
    • Offbeat
  • More
    • About
    • The Team
    • Advertise
    • Contribute
    • Our stance on climate change
    • Privacy Policy
    • Contact

© 2007-2019 ZME Science - Not exactly rocket science. All Rights Reserved.